Round Table Session: What are the advantages of POT balloon over conventional NCB
Release time:
2022-12-07
12 December @ 8:00 – 10:00 (CET time), 15:00-17:00 (Beijing time)
12 December @ 8:00 – 10:00 (CET time), 15:00-17:00 (Beijing time)
Join us for this broadcasted round table session to hear about the insight from well-known professors about POT technique and BrosMed POT balloon dilatation catheter (which is dedicated for coronary bifurcation stenting). Also, we will share the extensive research and clinical data of POT study to show the advantages of POT balloon over conventional Non-compliant balloon.
We’re excited to have Professor Shaoliang Chen (MD, PhD, FSCAI, FACC, FESC, JSCAI Editorial Board, China) as session chairman; Professor Antonio Colombo (MD, FACC, MSCAI, Deemed a “Legend in Cardiovascular Disease”, Italy), Prof. Dobrin Vassilev (MD, PhD, Bulgaria), Prof. Lefeng Wang (MD, PhD, China) and Dr. Choo Gim Hooi (MD, Malaysia) as our Panel Discussion, also with 3 Honored Speakers: Dr. Gregor Leibundgut (Switzerland), Dr. Stefano Galli (Italy) and Dr. Wangang Guo (China).
Please Scan the QR code on the poster or Click the Link to register and join with us and watch the live broadcast.
Stay tuned and don’t miss out on this exciting event!
Previous Article
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
